MedPath

INTERSHUNT TECHNOLOGIES, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:1
Completed:0

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

An Early Feasibility Study Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure

Not Applicable
Recruiting
Conditions
Heart Failure
Heart Failure With Reduced Ejection Fraction
Heart Failure NYHA Class III
Ambulatory Heart Failure, NYHA Class IV
First Posted Date
2025-03-05
Last Posted Date
2025-07-01
Lead Sponsor
InterShunt Technologies, Inc.
Target Recruit Count
20
Registration Number
NCT06859970
Locations
🇺🇸

St. Bernard's Healthcare, Jonesboro, Arkansas, United States

🇺🇸

Los Robles Health System, Thousand Oaks, California, United States

🇺🇸

Christ Hospital, Cincinnati, Ohio, United States

and more 1 locations

Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure

Not Applicable
Active, not recruiting
Conditions
Heart Failure
First Posted Date
2022-06-03
Last Posted Date
2023-03-01
Lead Sponsor
InterShunt Technologies, Inc.
Target Recruit Count
10
Registration Number
NCT05403372
Locations
🇬🇪

Tbilisi Heart and Vascular Clinic, Tbilisi, Georgia

News

No news found
© Copyright 2025. All Rights Reserved by MedPath